124 related articles for article (PubMed ID: 2068474)
1. Infections in patients in intensive care units: can the combination of a monobactam and a penicillin replace the classic combination of a beta-lactam agent and an aminoglycoside?
Colardyn F; Gala JL; Verschraegen G; Wauters G; Vogelaers D; Dive A; Claeys G; Magis A; Vandercam B; Mahieu P
Rev Infect Dis; 1991; 13 Suppl 7():S640-4. PubMed ID: 2068474
[TBL] [Abstract][Full Text] [Related]
2. [Bacterial infections in cancer patients without neutropenia. Comparison between 2 antibiotic combinations (aztreonam and oxacillin versus cefoxitin and tobramycin)].
Apice G; Beneduce G; Bruni GS; D'Aprile M; Perna M; Silvestro P; Villari P; Pergola M
Clin Ter; 1989 Nov; 131(3):177-82. PubMed ID: 2533029
[TBL] [Abstract][Full Text] [Related]
3. Aztreonam plus clindamycin versus tobramycin plus clindamycin in the treatment of intraabdominal infections.
Williams RR; Hotchkin D
Rev Infect Dis; 1991; 13 Suppl 7():S629-33. PubMed ID: 2068472
[TBL] [Abstract][Full Text] [Related]
4. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S
Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
[TBL] [Abstract][Full Text] [Related]
5. Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia.
Schentag JJ; Vari AJ; Winslade NE; Swanson DJ; Smith IL; Simons GW; Vigano A
Am J Med; 1985 Feb; 78(2A):34-41. PubMed ID: 3881947
[TBL] [Abstract][Full Text] [Related]
6. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
Rabinad E; Bosch-Perez A
Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
[TBL] [Abstract][Full Text] [Related]
7. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
[TBL] [Abstract][Full Text] [Related]
8. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
Birolini D; Moraes MF; de Souza OS
Chemotherapy; 1989; 35 Suppl 1():49-57. PubMed ID: 2659290
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli.
DeMaria A; Treadwell TL; Saunders CA; Porat R; McCabe WR
Antimicrob Agents Chemother; 1989 Aug; 33(8):1137-43. PubMed ID: 2679368
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of the combination of aztreonam with cefotaxime in the treatment of severe nosocomial pneumonia. Comparative study against amikacin combined with cefotaxime.
Torres A; de Celis R; Rabinad E; Marco F; Almela M; Deulofeu R; Rodriguez-Roisin R; Agusti Vidal A
Chemotherapy; 1989; 35 Suppl 1():15-24. PubMed ID: 2659289
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group.
Marco V; Gobernado M; Santos M; Rabinad E
Chemotherapy; 1989; 35 Suppl 1():81-8. PubMed ID: 2659295
[TBL] [Abstract][Full Text] [Related]
12. [Aztreonam versus tobramycin in acute pyelonephritis. A comparative study].
Gallego J; Jiménez Cruz JF; Gobernado M; Llopis B; Vidal J; Server G; Ruiz JL; David Vera C
Arch Esp Urol; 1989 Mar; 42(2):116-9. PubMed ID: 2660754
[TBL] [Abstract][Full Text] [Related]
13. Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient.
Louie TJ; Chubb H; Bow EJ; Conly JM; Harding GK; Rayner E; James M
Rev Infect Dis; 1985; 7 Suppl 4():S747-61. PubMed ID: 3909333
[TBL] [Abstract][Full Text] [Related]
14. [Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors].
Natali M; Tonini G; Tufo E; Leggio M; Carassai A; Lopez M
Clin Ter; 1989 Sep; 130(5):239-44. PubMed ID: 2530024
[TBL] [Abstract][Full Text] [Related]
15. Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure.
Erjavec Z; de Vries-Hospers HG; van Kamp H; van der Waaij D; Halie MR; Daenen SM
Scand J Infect Dis; 1994; 26(5):585-95. PubMed ID: 7855556
[TBL] [Abstract][Full Text] [Related]
16. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis.
Dratwa M; Glupczynski Y; Lameire N; Matthys D; Verschraegen G; Vaneechoutte M; Boelaert J; Schurgers M; Van Landuyt H; Verbeelen D
Rev Infect Dis; 1991; 13 Suppl 7():S645-7. PubMed ID: 2068475
[TBL] [Abstract][Full Text] [Related]
17. The clinical use of aztreonam.
Schönwald S; Schoss-Vidensek Z; Car V; Krznar B
Chemotherapy; 1989; 35 Suppl 1():45-8. PubMed ID: 2731450
[TBL] [Abstract][Full Text] [Related]
18. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
19. Comparative clinical evaluation of aztreonam versus aminoglycosides in gram-negative septicaemia.
Gudiol F; Pallarés R; Ariza X; Fernández-Viladrich P; Rufi G; Liñares J
J Antimicrob Chemother; 1986 May; 17(5):661-71. PubMed ID: 3722035
[TBL] [Abstract][Full Text] [Related]
20. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial.
Smith CR; Ambinder R; Lipsky JJ; Petty BG; Israel E; Levitt R; Mellits ED; Rocco L; Longstreth J; Lietman PS
Ann Intern Med; 1984 Oct; 101(4):469-77. PubMed ID: 6089633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
